abstract
autophagi
process
selfdigest
cytoplasm
organel
cellular
compon
recycl
reus
energi
product
evolutionarili
conserv
respons
metabol
stress
found
eukaryot
yeast
mammal
noteworthi
autophagi
also
associ
variou
pathophysiolog
condit
cellular
process
play
either
cytoprotect
cytopath
role
respons
varieti
stress
metabol
inflammatori
neurodegen
therapeut
stress
gener
believ
modul
activ
autophagi
target
specif
regulatori
molecul
autophagi
machineri
may
impact
diseas
process
thu
autophagi
may
repres
new
pharmacolog
target
drug
develop
therapeut
intervent
variou
human
disord
induct
inhibit
autophagi
use
small
molecul
compound
shown
promis
treatment
diseas
cancer
depend
context
induct
suppress
autophagi
may
exert
therapeut
effect
via
promot
either
cell
surviv
death
two
major
event
target
therapi
variou
disord
better
understand
biolog
autophagi
pharmacolog
autophagi
modul
potenti
facilit
develop
autophagybas
therapeut
intervent
sever
human
diseas
therapeut
target
autophagi
liter
mean
selfeat
greek
discov
half
centuri
ago
evolutionarili
conserv
genet
control
cellular
respons
nutrient
depriv
found
yeast
plant
worm
fli
mice
human
cellular
catabol
process
character
format
doublemembran
vesicl
autophagosom
cytosol
first
engulf
organel
cytoplasm
fuse
lysosom
form
autolysosom
content
degrad
recycl
synthesi
atp
variou
macromolecul
protein
levin
klionski
absenc
stress
basal
autophagi
may
function
housekeep
degrad
intracellular
damag
protein
organel
levin
klionski
form
selfdigest
unicellular
multicellular
organ
commonli
activ
time
nutrient
depriv
temporari
cellular
protect
mechan
lead
selfpreserv
maiuri
et
al
cellular
stress
prompt
cell
exit
cell
cycl
shrink
autodigest
longliv
protein
damag
organel
autophagi
recycl
fatti
acid
amino
acid
either
synthesi
macromolecul
oxid
mitochondria
maintain
cellular
atp
left
uncheck
howev
autophagi
potenti
caus
termin
selfabbrevi
benzoyl
ad
alzheim
diseas
akt
protein
kinas
b
ampk
ampactiv
protein
kinas
deforolimu
phenanthrenyl
trifluoromethyl
phenyl
acetamid
asyn
asynuclein
atg
autophagyrel
gene
pyrido
methanol
homolog
domain
temsirolimu
cma
chaperonemedi
autophagi
cq
chloroquin
cr
calor
restrict
dram
damageregul
autophagi
modul
eukaryot
elong
kinas
egfr
epiderm
growth
factor
receptor
amino
amino
ethoxycarbonyl
acid
ethyl
ester
hcq
hydroxychloroquin
hd
huntington
diseas
chaperon
heatshock
cognat
protein
htt
huntingtin
ifn
interferon
il
interleukin
inositol
inositol
receptor
ir
ischemiareperfus
phosphon
acid
lamp
lysosomalassoci
membran
protein
ethyl
amino
methyl
phenyl
light
chain
liver
kinas
hydrochlorid
phenyl
one
dihydrochlorid
mtor
mammalian
target
rapamycin
mtorc
mtor
signal
complex
hydroxi
methyl
phenyl
propanenitril
imidazo
benzamid
pd
parkinson
diseas
pe
phosphatidylethanolamin
furo
kinas
polyq
polyglutamin
n
benzamid
pten
phosphatas
tensin
homolog
everolimu
ro
reactiv
oxygen
speci
saha
vorinostat
sequestosom
n
sul
sulfaphenazol
trifluoromethyl
phenyl
h
tnfa
tumor
necrosi
factor
tsc
tuber
sclerosi
complex
up
ubiquitinproteasom
system
mammalian
homolog
uvrag
uv
radiat
resistanceassoci
gene
pyrazolo
phenyl
zvad
nbenzyloxycarbonylvalalaasp
autophagi
diseas
pharmacolog
consumpt
cannibalist
cell
death
certain
circumst
autophagi
also
consid
form
nonapoptot
cell
death
term
type
ii
program
cell
death
autophag
cell
death
bergmann
wherea
autophag
cell
death
rest
larg
circumstanti
evid
autophag
cell
surviv
support
direct
evolutionari
genet
biochem
studi
autophagi
induc
broad
rang
intracellular
extracellular
stress
degrad
protein
aggreg
oxid
lipid
damag
organel
even
intracellular
pathogen
thu
varieti
physiolog
pathophysiolog
role
develop
differenti
lifespan
extens
elimin
microorgan
antigen
present
ravikumar
et
al
recent
year
accumul
evid
point
import
function
role
autophagi
variou
human
diseas
instanc
becom
increasingli
clear
alter
autophagi
activ
associ
tumor
format
progress
well
alter
respons
cancer
therapi
janku
et
al
numer
studi
indic
autophagi
activ
tumor
cell
expos
certain
type
chemotherapi
target
therapi
janku
et
al
defect
autophagi
found
involv
prematur
age
rajawat
et
al
neurodegen
diseas
cardiovascular
disord
rubinsztein
et
al
addit
appear
defect
autophagi
lead
increas
suscept
infect
associ
autoimmun
inflammatori
diseas
deret
levin
deret
levin
et
al
recent
substanti
progress
made
identifi
gene
protein
signal
pathway
relat
molecular
mechan
involv
autophagi
regul
permit
manipul
autophagi
inhibit
activ
autophagyrel
gene
protein
use
genet
andor
pharmacolog
approach
notabl
increas
number
autophagyrel
gene
protein
pathway
found
aberr
alter
human
diseas
offer
novel
target
therapeut
intervent
inde
modul
autophag
process
alreadi
shown
promis
treatment
certain
human
diseas
autophagi
emerg
promis
attract
new
target
great
interest
pharmaceut
industri
recent
great
effort
made
develop
autophagybas
pharmacotherapi
variou
human
health
problem
review
provid
overview
current
understand
biolog
autophagi
role
autophagi
play
pathophysiolog
variou
human
disord
goal
show
autophagi
modul
may
lead
new
gener
therapeut
agent
treatment
variou
human
diseas
three
type
autophagi
defin
base
process
mechan
target
substrat
deliv
lysosom
degrad
macroautophagi
fig
chaperonemedi
autophagi
cma
fig
microautophagi
fig
macroautophagi
hereaft
refer
autophagi
involv
sequestr
intracellular
compon
protein
organel
newli
form
doublemembran
vesicl
term
autophagosom
subsequ
fuse
lysosom
degrad
schemat
process
autophagi
character
three
main
oper
step
weidberg
et
al
first
format
autophagosom
sequestr
cytoplasm
materi
vesicl
process
involv
three
stage
follow
initi
format
phagophor
nucleat
engulf
cytoplasm
materi
phagophor
elong
enclosur
phagophor
membran
elong
fusion
edg
form
autophagosom
second
fusion
autophagosom
lysosom
form
autolysosom
third
degrad
sequest
materi
recycl
energi
product
macroautophagi
classifi
two
type
follow
nonselect
autophagi
cargospecif
autophagi
includ
mitophagi
pexophagi
ribophagi
xenophagi
youl
narendra
mitophagi
mediat
select
elimin
damag
excess
mitochondria
play
essenti
role
maintain
mitochondri
quantiti
remov
damag
mitochondria
autophagi
requir
two
step
follow
induct
gener
autophagi
prime
damag
mitochondria
select
autophag
recognit
ding
yin
process
cma
cytosol
protein
recogn
heatshock
cognat
protein
chaperon
mediat
transloc
protein
surfac
lysosom
substrat
bind
lysosomalassoci
membran
protein
type
lead
protein
intern
degrad
kaushik
cuervo
cma
select
recogn
protein
contain
kferq
motif
ctermin
sequenc
particular
pentapeptid
consensu
motif
bind
region
recogn
specif
protein
deliveri
lysosom
necessari
suffici
degrad
substrat
cma
chiang
et
al
dice
cma
involv
follow
step
recognit
kferq
region
cytosol
protein
bind
substrat
protein
cytosol
tail
multimer
substrat
transloc
insid
lysosom
substrat
degrad
dissoci
monom
chiang
et
al
aria
cuervo
microautophagi
involv
direct
intern
cytoplasm
materi
lysosom
cellular
constitu
sequestr
lysosom
lumen
degrad
invagin
lysosom
membran
subsequ
pinch
form
small
vesicl
mortimor
et
al
autophagi
evolutionarili
conserv
eukaryot
yeast
mammal
miscellan
physiolog
role
includ
adapt
starvat
clearanc
intracellular
protein
organel
develop
differenti
lifespan
extens
elimin
microorgan
antigen
present
basal
level
autophagi
gener
view
cellular
housekeep
crucial
qualiti
control
integr
intracellular
protein
metabol
type
stress
induct
autophagi
import
intracellular
gener
amino
acid
nutrient
molecul
cellular
surviv
convers
excess
autophagi
caus
nonapoptot
program
cell
death
autophagydepend
cellular
homeostasi
two
known
cellular
mechan
protein
degrad
ubiquitinproteasom
system
up
autophagylysosom
system
up
major
pathway
degrad
shortliv
protein
hershko
ciechanov
wherea
autophagi
mainli
respons
degrad
longliv
protein
cellular
content
mechan
larg
structur
organel
protein
aggreg
degrad
rabinowitz
white
normal
condit
low
level
constitut
autophagi
particip
maintain
cellular
homeostasi
degrad
recycl
unnecessari
excess
cellular
compon
elimin
abnorm
age
potenti
harm
molecul
organel
remov
intracellular
pathogen
levin
impair
autophagi
may
result
accumul
abnorm
misfold
protein
aggreg
neural
cell
hepatocyt
mice
knockout
autophagi
gene
abnorm
intracellular
protein
macroautophagi
begin
engulf
cytoplasm
materi
phagophor
sequest
materi
doublemembran
vesicl
ie
autophagosom
autophagosom
fuse
lysosom
form
autolysosom
cytoplasm
materi
degrad
lysosom
initi
step
autophagosom
format
requir
complex
iii
complex
two
conjug
system
essenti
elong
enclosur
step
autophagosom
format
lipid
conjug
lead
convers
solubl
form
autophag
vesicleassoci
form
commonli
use
marker
autophagi
mtor
play
critic
role
regul
autophagi
nutrientrich
condit
mtor
activ
inhibit
autophagi
repress
activ
mammalian
homolog
growth
factor
insulin
insulinlik
growth
factor
activ
class
pathway
phosphoryl
tuber
sclerosi
complex
prevent
format
protein
complex
result
activ
mtor
b
chaperonemedi
autophagi
chaperonemedi
autophagi
cytosol
protein
bind
receptor
chaperonedepend
manner
transloc
lysosom
lead
intern
degrad
c
microautophagi
microautophagi
involv
direct
sequestr
cellular
compon
lysosom
invagin
lysosom
membran
autophagi
diseas
pharmacolog
accumul
form
aggreg
inclus
hara
et
al
likewis
mice
defici
autophagi
gene
accumul
intracellular
ubiquitin
aggreg
cytoplasm
hepatocyt
neuron
komatsu
et
al
komatsu
et
al
observ
indic
continu
clearanc
diffus
cytosol
protein
basal
autophagi
essenti
homeostasi
autophagi
play
key
role
qualiti
control
cellular
compon
remov
abnorm
potenti
harm
protein
autophagi
also
involv
monitor
qualiti
import
organel
mitochondria
mice
defici
show
multipl
cellular
abnorm
includ
appear
concentr
membran
structur
deform
mitochondria
komatsu
et
al
heart
mice
display
disorgan
sarcomer
structur
mitochondri
misalign
aggreg
nakai
et
al
mitochondria
loss
integr
select
remov
autophagi
process
term
mitophagi
marino
lopezotin
rat
hepatocyt
nutrient
depriv
initi
mitochondri
depolar
subsequ
sequestr
mitochondria
autophagosom
elmor
et
al
although
select
degrad
mitochondria
mitophagi
vital
cellular
homeostasi
molecular
mechan
mitophagi
remain
incomplet
understood
far
identifi
critic
regul
mitophagi
kanki
klionski
kanki
et
al
okamoto
et
al
mammal
autophag
degrad
depolar
mitochondria
initi
mitochondri
transloc
parkin
follow
ubiquitin
mitochondri
protein
recruit
direct
mitochondria
autophagosom
geisler
et
al
recent
member
membran
curvaturedriv
endophilin
famili
protein
found
requir
autophagydepend
clearanc
damag
mitochondria
takahashi
et
al
autophagi
also
play
critic
role
develop
differenti
instanc
autophagi
vital
preimplant
develop
period
oocyt
fertil
earli
postnat
period
neonat
starvat
mizushima
levin
alter
autophagi
affect
embryogenesi
includ
midembryon
develop
key
autophagyregulatori
gene
requir
engulf
apoptot
cell
morphogenesi
specif
organ
late
embryon
develop
autophagi
enabl
cell
undergo
structur
remodel
contribut
cellular
differenti
erythropoiesi
lymphopoiesi
adipogenesi
rubinsztein
et
al
autophagydepend
cellular
surviv
differ
type
stress
eg
nutrient
depriv
growth
factor
deplet
hypoxia
cytotox
insult
activ
autophagi
gener
intracellular
metabol
substrat
mainten
cellular
energi
demand
amino
acid
fatti
acid
gener
autophag
degrad
membran
protein
lipid
may
provid
essenti
nutrient
surviv
organ
subject
varieti
stress
rabinowitz
white
one
typic
trigger
autophagi
nutrient
starvat
induc
autophagi
yeast
plant
cell
mammalian
cell
whole
anim
provid
nutrient
energi
support
surviv
autophagydefect
cell
fail
maintain
physiolog
level
amino
acid
subject
starvat
intracellular
extracellular
concentr
amino
acid
decreas
autophagydefici
cell
anim
greater
extent
wildtyp
litterm
yeast
cell
harbor
mutant
total
pool
intracellular
amino
acid
reduc
wildtyp
cell
maintain
amino
acid
concentr
compat
life
onodera
ohsumi
neonat
mice
decreas
amino
acid
concentr
plasma
tissu
kuma
et
al
mice
lower
level
amino
acid
also
die
earlier
birth
compar
wildtyp
anim
komatsu
et
al
amino
acid
fatti
acid
gener
autophagi
use
tricarboxyl
acid
tca
cycl
maintain
atp
product
mitochondria
addit
amino
acid
use
protein
synthesi
impair
protein
synthesi
mutant
yeast
cell
much
sever
wildtyp
cell
starvat
onodera
ohsumi
yeast
autophagydefect
cell
suscept
starvationinduc
damag
upon
nitrogen
starvat
plant
mutant
autophagi
gene
show
defect
develop
includ
acceler
senesc
enhanc
chlorosi
hanaoka
et
al
yoshimoto
et
al
postnat
surviv
time
starv
mice
defici
less
hour
prolong
forc
milk
feed
indic
import
nutrient
suppli
deriv
neonat
autophagi
support
surviv
life
kuma
et
al
similarli
mice
defici
suffer
sever
nutrient
energi
insuffici
shortli
birth
komatsu
et
al
equal
import
cellular
autophagi
also
play
cytoprotect
prosurviv
role
stress
condit
growth
factor
depriv
lum
et
al
treatment
chemotherapi
antiinfect
agent
maiuri
et
al
studi
provid
compel
evid
nutrient
gener
autophagi
import
surviv
stress
support
notion
autophagi
selfprotect
mechan
live
organ
variou
stress
condit
autophag
cell
death
beyond
studi
role
autophagi
cellular
surviv
also
extens
interest
autophagyassoci
cell
death
refer
type
ii
program
cell
death
earli
autophag
vacuol
contain
organel
mitochondria
first
observ
die
anim
cell
ashford
porter
area
investig
confound
possibl
appear
autophagi
dead
die
cell
unsuccess
cellular
attempt
surviv
mention
previous
cell
organ
defici
autophagi
may
die
rapidli
rather
slowli
subsequ
studi
found
autophag
cell
death
often
occur
group
cell
entir
tissu
die
develop
die
cell
contain
autophag
vacuol
cytoplasm
baehreck
recent
autophag
cell
death
observ
tumor
cell
treat
chemoprevent
chemotherapeut
agent
resveratrol
opipari
et
al
arsen
trioxid
kanzawa
et
al
tamoxifen
bursch
et
al
support
role
autophagi
cell
death
provid
via
use
autophagi
inhibitor
rescu
cell
death
result
autophagi
exampl
inhibitor
class
iii
kinas
block
initi
step
autophagi
report
suppress
autophagi
inhibit
cell
death
sever
cell
line
subject
variou
drug
treatment
includ
tamoxifen
bursch
et
al
tumor
necrosi
factor
tnfa
bacteri
toxin
bursch
studi
also
show
knockdown
key
autophagi
gene
reduc
cell
death
small
molecul
compound
n
promot
cell
death
renal
cell
carcinoma
vitro
vivo
induc
autophagi
inhibit
autophagi
smallinterf
rna
sirna
decreas
sensit
tumor
cell
turcott
et
al
nonapoptot
cell
death
induc
zvad
caspas
inhibitor
decreas
cell
cotreat
either
autophagi
inhibitor
wortmannin
subject
rnaimedi
knockdown
suggest
inhibit
caspas
arrest
apoptosi
activ
autophag
cell
death
yu
et
al
bax
bak
murin
embryon
fibroblast
mef
treat
etoposid
topoisomeras
ii
poison
staurosporin
prototyp
atpcompetit
kinas
inhibitor
two
induc
apoptosi
nonapoptot
cell
death
accompani
autophag
vacuol
reduc
knock
shimizu
et
al
autophag
cell
death
reveal
apoptosi
block
maiuri
et
al
addit
excess
autophagi
caus
cannibalist
cell
death
bergmann
although
numer
scenario
autophagyassoci
cell
death
may
occur
import
signific
autophagi
promot
cell
death
relationship
apoptot
cell
death
still
subject
intens
investig
number
exampl
cell
death
associ
autophagi
question
import
autophag
process
cell
death
recent
review
kroemer
levin
certain
studi
suggest
inhibit
autophagi
may
result
either
delay
partial
inhibit
rather
prevent
cell
death
inhibit
autophagi
pharmacolog
agent
genet
manipul
also
may
offtarget
effect
cellular
function
question
whether
cell
death
truli
occur
due
autophagi
alon
remain
clarifi
past
decad
seen
remark
elucid
mani
molecular
mechan
pathway
critic
involv
regul
autophagi
review
studi
facilit
understand
implic
autophagi
human
health
diseas
molecular
regul
autophagi
studi
gene
gene
product
involv
regul
autophagi
advanc
knowledg
molecular
basi
cellular
process
date
autophagyrel
gene
atg
identifi
yeast
function
format
autophagosom
yang
klionski
atg
protein
found
yeast
mammalian
homolog
suggest
molecular
machineri
autophagi
oper
yeast
also
use
eukaryot
cell
mammalian
homolog
yeast
autophagi
gene
first
identifi
autophagi
gene
mammalian
cell
li
et
al
initi
step
autophagosom
format
requir
iii
complex
contain
class
iii
simonsen
tooz
recent
found
interact
addit
protein
includ
uv
radiat
resistanceassoci
gene
uvrag
product
liang
et
al
itakura
et
al
li
et
al
activ
molecul
autophagi
protein
fimia
et
al
protein
present
complex
act
induc
autophagi
rubicon
protein
neg
regul
autophagi
bind
reduc
activ
impair
format
autophagosom
zhong
et
al
play
key
role
earli
stage
autophagi
form
complex
enhanc
kinas
activ
promot
autophagosom
gener
ganley
et
al
hara
mizushima
hosokawa
et
al
compon
autophagi
diseas
pharmacolog
complex
mostli
conserv
yeast
human
serinethreonin
kinas
mammalian
function
homolog
yeast
respect
promot
format
selfinteract
complex
correl
kinas
activ
amount
autophagi
yeh
et
al
recent
identifi
regul
directli
bind
enhanc
activ
autophagi
kraft
et
al
two
ubiquitinlik
conjug
system
complex
complex
pe
particip
elongationenclosur
step
critic
autophagosom
format
conjug
system
conserv
variou
eukaryot
first
ubiquitinlik
system
conjug
ubiquitinactiv
enzym
ubiquitinconjug
enzym
respect
mizushima
et
al
bind
ctermin
glycin
activ
cystein
site
form
intermedi
complex
via
thioester
bond
subsequ
activ
atp
hydrolysi
transfer
ctermin
glycin
coval
bind
intern
lysin
residu
form
final
conjug
conjug
interact
noncoval
mizushima
et
al
complex
associ
phagophor
dissoci
format
autophagosom
complet
yorimitsu
klionski
second
conjug
system
involv
cleavag
lipid
ichimura
et
al
cleav
near
ctermin
glycin
residu
cystein
proteas
subsequ
activ
transfer
eventu
conjug
lipid
pe
detect
intermedi
vesicl
complet
autophagosom
complex
transport
lysosomevacuol
degrad
along
cargo
least
three
homolog
mammalian
cell
golgiassoci
atpas
enhanc
kda
gabarap
gaminobutyr
acid
type
receptorassoci
protein
microtubuleassoci
protein
light
chain
protein
modifi
lipid
manner
occur
yeast
local
autophagosom
kabeya
et
al
mammalian
cell
light
chain
cleav
form
cytosol
solubl
cleav
convert
membraneassoci
form
conjug
lipid
pe
kabeya
et
al
cleav
product
insert
within
inner
outer
membran
vesicl
autophagosom
format
intens
character
like
yeast
commonli
use
marker
mammalian
autophagosom
addit
remain
matur
autophagosom
fusion
lysosom
complet
thu
fusion
autophagosom
lysosom
assess
colabel
lysosomeassoci
membran
protein
weidberg
et
al
sequestosom
ubiquitinbind
scaffold
protein
bind
directli
via
specif
sequenc
motif
degrad
autophag
process
also
link
ubiquitin
protein
autophag
machineri
enabl
degrad
lysosom
pankiv
et
al
autophagi
suppress
markedli
accumul
contrast
amount
decreas
autophagi
activ
thu
often
use
marker
autophag
flux
anoth
commonli
use
method
measur
autophagi
flux
monitor
convers
presenc
lysosom
cystein
andor
aspart
proteinas
inhibitor
day
pepstatin
signal
pathway
regul
autophagi
mammalian
target
rapamycin
mammalian
target
rapamycin
mtor
serin
threonin
protein
kinas
key
regul
cell
growth
prolifer
mtor
regul
variou
cellular
function
energi
metabol
translat
initi
cytoskelet
organ
schmelzl
hall
recent
found
mtor
signal
pathway
also
may
regul
autophagi
fig
activ
nutrient
growth
factor
hormon
insulin
mtor
inhibit
autophagi
mtor
present
two
structur
function
distinct
protein
complex
known
consist
mtor
mammalian
lethal
protein
raptor
regulatoryassoci
protein
mtor
prolinerich
akt
substrat
kda
deptor
dep
domain
contain
mtorinteract
protein
rapamycin
sensit
contain
mtor
rictor
rapamycininsensit
companion
mammalian
stressactiv
map
kinaseinteract
protein
protein
observ
observ
sabatini
pearc
et
al
downstream
activ
respons
mitogen
stimuli
nutrient
avail
hay
sonenberg
growth
factor
insulin
insulinlik
growth
factor
bind
receptor
tyrosin
kinas
lead
autophosphoryl
receptor
subsequ
phosphoryl
insulin
receptor
substrat
ir
phosphoryl
insulin
receptor
substrat
recruit
activ
class
phosphoryl
tuber
sclerosi
complex
prevent
format
abil
act
gtpaseactiv
protein
rheb
rheb
activ
bound
gtp
inhibit
akt
phosphoryl
allow
rhebgtp
accumul
activ
mtor
proud
phosphatas
tensin
homolog
pten
phosphatas
antagon
signal
aktpkb
pathway
activ
autophagi
shaw
cantley
gener
activ
indirectli
regul
akt
protein
kinas
b
whose
activ
prevent
tuberoussclerosi
mediat
inhibit
rheb
activ
mtor
known
neg
regul
autophagi
although
precis
mechan
control
autophagi
direct
target
remain
unclear
believ
act
two
way
first
inhibit
associ
nutrientrich
condit
activ
induc
phosphoryl
prevent
associ
subject
nutrient
depriv
rapamycin
treatment
rapidli
dephosphoryl
upon
inactiv
show
high
affin
format
complex
result
activ
subsequ
induct
autophagi
kamada
et
al
kamada
et
al
human
homolog
also
direct
substrat
mtor
jung
et
al
second
inactiv
phosphoryl
protein
inactiv
lead
dephosphoryl
activ
consequ
induc
autophagi
condit
starvat
rapamycin
treatment
kim
et
al
laboratori
particularli
interest
elong
factor
kinas
enzym
catalyz
phosphoryl
protein
involv
transloc
step
peptidechain
elong
phosphoryl
decreas
affin
ribosom
therebi
termin
elong
shown
fig
kinas
exquisit
control
mtor
ampactiv
protein
kinas
ampk
horman
et
al
energi
abund
inhibit
activ
mtor
protein
elong
occur
contrast
energi
defici
activ
mtor
decreas
activ
therebi
inhibit
peptid
elong
conserv
growth
factor
bind
receptor
activ
receptor
tyrosin
kinas
stimul
ra
akt
phosphoryl
inhibit
complex
dampen
inhibitori
effect
rheb
lead
activ
consequ
autophagi
inhibit
affect
complex
format
pten
inhibit
signal
autophagypromot
signal
ampk
phosphoryl
activ
activ
ampk
phosphoryl
activ
lead
inactiv
mtor
induct
autophagi
ampk
also
caus
inactiv
mtor
directli
phosphoryl
mtor
bind
partner
raptor
ampk
also
regul
coordin
induct
autophagi
signal
cascad
caus
activ
autophagi
nuclear
stimul
autophagi
transcriptiondepend
fashion
activ
express
dram
sestrin
contrast
cytoplasm
respons
inhibit
autophagi
famili
antiapoptot
protein
interact
exert
inhibitori
effect
autophagi
convers
proapoptot
protein
stimulatori
effect
autophagi
disrupt
associ
antiapoptot
protein
intracellular
ip
neg
regul
autophagi
via
mtorindepend
mechan
autophagi
diseas
pharmacolog
energi
sever
line
evid
suggest
direct
link
activ
autophagi
exampl
found
eefk
act
posit
regul
autophagi
environment
metabol
stress
includ
nutrient
depriv
wu
et
al
growth
factor
inhibit
endoplasm
reticulum
stress
energi
stress
caus
glycolyt
inhibitor
wu
et
al
b
ampactiv
protein
kinas
activ
protein
kinas
ampk
serinethreonin
protein
kinas
chief
sensor
cellular
energi
regul
metabol
glucos
lipid
respons
alter
nutrient
intracellular
atp
concentr
ampk
activ
intracellular
ampatp
ratio
increas
ampk
phosphoryl
differ
site
variou
kinas
phosphoryl
ampk
within
catalyt
subunit
necessari
activ
kinas
recent
studi
identifi
liver
kinas
major
upstream
activ
kinas
ampk
ca
calmodulindepend
protein
kinas
kinaseb
camkkb
transform
growth
factorbactiv
kinas
major
kinas
phosphoryl
ampk
caus
activ
kinas
momcilov
et
al
carl
et
al
ampk
also
contain
phosphoryl
site
asubunit
includ
phosphoryl
site
involv
activ
kinas
wood
et
al
nativ
b
subunit
ampk
phosphoryl
three
site
mitchelhil
et
al
known
mutat
site
lead
inhibit
ampk
wherea
mutat
site
effect
enzym
activ
warden
et
al
ampk
also
particip
regul
cellular
function
includ
mainten
mitochondri
homeostasi
cell
polar
cell
growth
prolifer
hardi
studi
also
reveal
ampk
import
regul
autophagi
meley
et
al
liang
et
al
matsui
et
al
herreromartin
et
al
ampkmedi
suppress
mtor
control
raptor
two
substrat
ampk
activ
ampk
energi
defici
directli
phosphoryl
enhanc
function
lead
suppress
key
downstream
target
inoki
et
al
altern
ampk
regul
mtor
signal
directli
phosphoryl
mtor
bind
partner
raptor
two
conserv
serin
residu
phosphoryl
enhanc
bind
raptor
result
inactiv
raptor
gwinn
et
al
ampk
also
direct
link
autophagi
interact
phosphoryl
fig
ampk
bind
ntermin
prolin
serin
ps
rich
domain
interact
requir
autophagi
herreromartin
et
al
furthermor
ampk
associ
directli
phosphoryl
sever
site
modif
requir
activ
respons
nutrient
depriv
egan
et
al
mack
et
al
report
ampk
interact
phosphoryl
ampkdepend
phosphoryl
import
regul
local
result
increas
autophagi
effici
similarli
glucos
starvat
ampk
promot
autophagi
directli
phosphoryl
thu
activ
kim
et
al
contrast
shang
cowork
found
undergo
dramat
dephosphoryl
upon
starvat
dephosphoryl
lead
dissoci
ampk
becom
activ
autophagi
induct
c
famili
protein
famili
protein
initi
identifi
character
regul
cell
surviv
death
recent
reveal
protein
famili
control
autophag
process
well
antiapoptot
famili
member
includ
bclxl
bclwl
also
inhibit
autophagi
fig
convers
proapoptot
homolog
protein
bad
noxa
puma
bik
stimul
autophagi
maiuri
et
al
exampl
antiapoptot
protein
interact
receptor
domain
domain
therebi
inhibit
autophagi
pattingr
et
al
interact
inhibit
nutrient
depriv
lead
releas
activ
autophagi
protein
domain
competit
disrupt
associ
induc
autophagi
mitophagi
induc
hypoxia
occur
hypoxia
induc
depend
transcript
activ
disrupt
interact
bellot
et
al
wide
appreci
antiapoptot
also
antiautophag
protein
tumor
suppressor
protein
transcript
factor
transactiv
proapoptot
cell
cyclearrest
gene
frequent
inactiv
mutat
cancer
cell
vousden
lane
found
inactiv
trigger
autophagi
vitro
vivo
tasdemir
et
al
tasdemir
et
al
found
introduct
wildtyp
cell
inhibit
autophagi
wherea
forc
express
nucleusrestrict
form
fail
suppress
autophagi
cell
suggest
cytoplasm
respons
inhibit
autophagi
addit
mani
differ
induc
autophagi
stimul
proteasomemedi
degrad
inhibit
degrad
prevent
activ
autophagi
tasdemir
et
al
contrast
nuclear
stimul
autophagi
transcriptiondepend
fashion
activ
express
autophagyinduc
gene
damageregul
autophagi
modul
dram
crighton
et
al
sestrin
maiuri
et
al
also
activ
autophagi
inhibit
mtor
ampkdepend
manner
chen
debnath
addit
sestrin
sestrin
two
target
gene
identifi
critic
link
activ
mtor
inhibit
budanov
karin
thu
modul
autophagi
dual
way
depend
cellular
local
nuclear
activ
autophagi
transcript
regul
wherea
cytoplasm
inhibit
autophagi
fig
depend
context
autophagi
play
either
cytoprotect
cytopath
role
differ
pathophysiolog
process
surprisingli
dysregul
autophagi
contribut
pathogenesi
variou
human
diseas
includ
cancer
obes
cardiac
diseas
neurodegener
age
infecti
inflammatori
diseas
shintani
klionski
levin
yuan
levin
kroemer
rubinsztein
et
al
liu
et
al
tabl
associ
autophagi
cancer
complex
role
autophagi
may
differ
differ
stage
diseas
earli
stage
tumor
develop
autophagi
may
prevent
genom
instabl
suppress
growth
precancer
cell
act
tumor
suppressor
gozuacik
kimchi
later
cours
diseas
autophagi
may
favor
abil
cancer
cell
surviv
metabol
therapeut
stress
therebi
promot
tumor
progress
autophagi
suppress
tumor
initi
gener
accept
autophagi
tumor
suppressor
function
defect
autophagi
contribut
tumor
develop
malign
transform
cell
often
display
lower
basal
autophag
activ
normal
counterpart
exampl
autophag
activ
lower
primari
hepatocellular
tumor
cell
normal
hepatocyt
rat
liver
carcinogenesi
model
kisen
et
al
identif
gene
requir
autophagi
provid
opportun
use
genet
approach
investig
role
autophagi
cancer
develop
accordingli
suppress
effect
autophagi
tumorigenesi
evalu
use
differ
model
defici
specif
autophagi
factor
tabl
mice
system
mosaic
delet
mice
liverspecif
defici
develop
benign
tumor
liver
suggest
autophagi
critic
suppress
spontan
tumorigenesi
model
takamura
et
al
mice
heterozyg
disrupt
show
increas
frequenc
spontan
cancer
qu
et
al
yue
et
al
protein
express
high
level
normal
breast
epitheli
cell
much
lower
express
breast
cancer
cell
line
ectop
express
cell
activ
autophagi
inhibit
cellular
prolifer
clonogen
suppress
tumorigenesi
mous
xenograft
model
function
also
inhibit
prolifer
tumor
cell
line
monoallel
delet
observ
specimen
human
breast
ovarian
prostat
cancer
aita
et
al
shintani
klionski
besid
sever
compon
autophag
machineri
found
possess
tumor
suppressor
function
exampl
mice
defici
show
increas
suscept
chemic
induc
fibrosarcoma
marino
et
al
uvrag
posit
regul
iii
complex
monoallel
delet
high
frequenc
human
colon
cancer
suppress
prolifer
tumorigen
human
colon
cancer
cell
liang
et
al
knockout
induc
autophagi
interact
activ
iii
complex
enhanc
develop
spontan
tumor
mice
takahashi
et
al
thu
autophagi
gene
may
serv
certain
circumst
tumor
suppressor
mutat
autophagi
gene
promot
tumorigenesi
autophagi
also
posit
regul
tumor
suppressor
gene
neg
regul
oncogen
signal
pathway
class
signal
pathway
promot
cell
growth
mutat
sever
protein
pathway
found
high
incid
common
human
malign
akt
signal
pathway
activ
autophagi
often
reduc
instanc
wang
et
al
found
essenti
autophagyregulatori
protein
target
akt
aktmedi
phosphoryl
lead
suppress
autophagi
associ
oncogenesi
provid
evid
role
aktmedi
downregul
autophagi
oncogen
process
convers
tumor
suppressor
pten
antagon
signal
akt
pathway
activ
autophagi
arico
et
al
mutat
pten
result
constitut
activ
akt
signal
pathway
suppress
autophagi
tumor
format
tumor
suppressor
stimul
autophagi
inhibitori
effect
autophagi
diseas
pharmacolog
rubinsztein
et
al
therefor
autophagi
gene
control
autophag
activ
oncogen
tumor
suppressor
gene
also
modul
cellular
process
tumor
initi
develop
influenc
mechan
autophagi
suppress
tumor
initi
develop
appear
includ
limit
accumul
damag
protein
organel
mitochondria
prevent
genom
instabl
subsequ
cellular
transform
jin
mathew
et
al
limit
inflamm
caus
necrosi
degenhardt
et
al
case
chronic
infect
toxin
exposur
defect
autophag
dispos
caus
chronic
tissu
damag
inflamm
may
contribut
cancer
amaravadi
et
al
also
autophagi
inhibit
tumor
growth
degrad
protein
requir
cell
prolifer
altern
autophagi
may
protect
tumor
initi
develop
favor
cellular
differenti
increas
protein
catabol
promot
autophag
cell
death
autophagi
promot
tumor
progress
tumor
enlarg
cancer
cell
may
face
metabol
stress
nutrient
growth
factor
depriv
hypoxia
due
insuffici
vascular
addit
cancer
treatment
radiat
chemotherapi
socal
target
therapi
includ
disrupt
angiogenesi
inhibit
function
proteasom
disrupt
signal
pathway
creat
form
cellular
stress
circumst
autophagi
may
protect
viabil
tumor
cell
provid
nutrient
energi
degrad
cytoplasm
compon
recycl
amino
acid
fatti
acid
demonstr
blunt
autophagi
imped
earli
stage
autophagi
use
inhibit
format
autophagolysosom
use
hydroxychloroquin
hcq
bafilomycin
silenc
express
rna
interfer
facilit
death
starv
cancer
cell
boya
et
al
autophagi
may
protect
cancer
cell
oxid
stress
dna
damag
caus
chemotherapeut
agent
elimin
damag
macromolecul
organel
allow
continu
surviv
cancer
cell
therebi
contribut
drug
resist
inhibit
autophagi
shown
enhanc
efficaci
anticanc
drug
janku
et
al
type
cancer
cell
particularli
harbor
activ
ra
oncogen
depend
autophag
activ
surviv
even
absenc
extern
stressor
mancia
kimmelman
vitro
vivo
studi
found
express
oncogen
ra
increas
autophagi
may
support
transform
tumor
growth
adapt
cellular
stress
maintain
energi
level
guo
et
al
kim
et
al
lock
et
al
yang
et
al
moreov
radiotherapi
chemotherapi
constitut
upregul
autophagi
may
favor
dormanc
state
residu
cancer
cell
includ
cancer
stem
cell
may
contribut
tumor
recurr
progress
white
et
al
senesc
state
cellcycl
arrest
may
serv
tumor
suppressor
suggest
mechan
underli
tumor
dormanc
mediat
autophagi
gewirtz
demonstr
autophagi
mediat
rasinduc
senesc
inhibit
autophagi
delay
senesc
cancer
cell
young
et
al
futur
horizon
autophagi
cancer
autophagi
appear
doubleedg
sword
cancer
tumorsuppress
tumorpromot
properti
differ
stage
cancer
one
hand
promot
autophagi
prevent
persist
tissu
damag
chronic
inflamm
might
benefici
set
cancer
prevent
hand
block
autophagymedi
surviv
tumor
cell
probabl
advantag
treatment
cancer
thu
modul
autophagi
appear
promis
complex
new
approach
cancer
prevent
treatment
although
benefit
context
depend
determin
modul
autophagi
cancer
therapi
excit
challeng
provid
new
insight
cancer
biolog
approach
enabl
cancer
erad
obes
phenotyp
express
imbal
energi
homeostasi
imbal
accompani
emerg
metabol
oxid
stress
may
lead
inflammatori
respons
organel
dysfunct
chronic
exposur
high
energi
nutrient
intak
increas
demand
synthet
degrad
machineri
tissu
liver
adipos
tissu
pancrea
central
metabol
homeostasi
recent
studi
shed
light
role
autophagi
regul
lipid
metabol
insulin
sensit
ineffect
handl
macromolecul
lipid
glycogen
could
compromis
metabol
function
liver
blunt
action
insulin
found
downregul
autophagi
hepatocyt
genet
dietari
model
obes
suppress
express
vitro
vivo
result
defect
insulin
signal
elev
endoplasm
reticulum
stress
contrast
restor
express
liver
limit
endoplasm
reticulum
stress
enhanc
action
insulin
system
glucos
toler
obes
mice
observ
indic
autophagi
import
compon
insulin
signal
autophagi
diseas
pharmacolog
reduc
autophagi
increas
endoplasm
reticulum
stress
may
lead
insulin
resist
autophagi
critic
role
normal
adipogenesi
inhibit
autophagi
antiobes
insulinsensit
effect
goldman
et
al
mice
delet
adipos
tissu
exhibit
enhanc
insulin
sensit
higher
level
basal
physic
activ
resist
obes
fed
highfat
diet
obes
increas
risk
type
diabet
obes
size
number
adipocyt
increas
result
expans
adipos
tissu
gain
adipos
tissu
particular
viscer
adipos
caus
adipocyt
dysfunct
may
play
role
develop
insulin
resist
obesitylink
complic
lavallard
et
al
type
diabet
character
glucos
intoler
insulin
resist
rel
insulin
defici
jung
et
al
mutant
mice
show
impair
glucos
toler
inappropri
concentr
circul
insulin
reduc
bcell
mass
pancreat
insulin
content
evid
indic
autophagi
necessari
mainten
structur
mass
function
pancreat
b
cell
indic
impair
autophagi
may
contribut
insulin
defici
hyperglycemia
result
abnorm
turnov
function
cellular
organel
ebato
et
al
jung
et
al
myocardium
autophagi
occur
low
level
normal
condit
defect
process
caus
cardiac
dysfunct
heart
failur
stress
condit
autophagi
rapidli
increas
play
protect
role
promot
cell
surviv
excess
autophagi
howev
may
lead
cell
death
rothermel
hill
gustafsson
gottlieb
increas
evid
suggest
defect
autophagi
associ
heart
disord
includ
congest
heart
failur
cardiomyopathi
danon
diseas
tabl
accumul
autophagosom
observ
myocardi
biopsi
sampl
patient
cardiovascular
diseas
coronari
arteri
diseas
hypertens
aortic
valvular
diseas
congest
heart
failur
terman
brunk
report
basal
autophagi
help
maintain
cardiomyocyt
function
surviv
exampl
myocardialspecif
defici
autophagi
gene
caus
cardiomyopathi
adult
mice
character
hypertrophi
contractil
dysfunct
nakai
et
al
cultur
cardiac
myocyt
induct
autophagi
reduc
accumul
misfold
protein
intracellular
aggreg
known
contribut
cardiac
diseas
pattison
robbin
mice
defici
show
excess
accumul
autophag
vacuol
impair
autophag
degrad
longliv
protein
may
contribut
incid
cardiomyopathi
nishino
et
al
tanaka
et
al
apart
appar
role
maintain
normal
function
heart
autophagi
also
adapt
respons
protect
heart
variou
stress
activ
autophagi
stress
heart
provid
energi
substrat
promot
cellular
remodel
believ
autophag
activ
cardiac
myocyt
provid
necessari
energi
sourc
period
birth
suckl
kuma
et
al
found
autophagi
trigger
ischemia
homeostat
mechan
reduc
apoptosi
deleteri
effect
chronic
ischemia
yan
et
al
inhibit
autophagi
hasten
heart
failur
acceler
ventricular
dysfunct
increas
mortal
mice
harbor
abcrystalin
mutant
indic
autophagi
act
adapt
respons
proteotox
model
heart
diseas
tannou
et
al
autophagi
protect
respons
toxic
lipopolysaccharid
neonat
rat
cardiomyocyt
damag
organel
remov
hicksonbick
et
al
found
remov
depolar
mitochondria
mitophagi
play
critic
role
protect
cardiac
muscl
cell
subject
ischem
stress
huang
et
al
cardiacspecif
defici
gene
caus
phenotyp
abnorm
earli
stage
cardiogenesi
normal
condit
result
sever
cardiac
dysfunct
treatment
pressur
overload
badrenerg
stress
nakai
et
al
recent
report
autophagi
play
protect
role
myocardi
cell
subject
ischemia
reperfus
ir
inhibit
autophagi
render
cell
sensit
apoptosi
ir
hamacherbradi
et
al
consist
observ
upregul
autophagi
induc
ir
constitut
protect
respons
apoptot
cell
death
remov
damag
mitochondria
hamacherbradi
et
al
also
appar
contradictori
report
excess
induct
autophagi
underli
autophag
cell
death
loss
cardiomyocyt
martinet
et
al
tabl
hypothesi
support
report
dead
die
cardiomyocyt
show
characterist
autophagi
increas
autophagi
associ
heart
failur
akazawa
et
al
provid
evid
suggest
loss
myocardi
cell
caus
autophag
cell
death
play
causal
role
pathogenesi
heart
failur
observ
degener
cardiomyocyt
mous
heart
exhibit
characterist
indic
autophag
cell
death
sever
studi
report
induct
autophagi
contribut
cell
death
ir
valentim
et
al
found
inhibit
autophagi
knockdown
treatment
enhanc
cell
surviv
cardiac
myocyt
treat
ir
activ
autophagi
cardiomyocyt
may
also
contribut
heart
failur
caus
pressur
overload
zhu
et
al
evidenc
observ
inhibit
autophagi
diminish
patholog
remodel
induc
sever
pressur
stress
convers
increas
autophag
activ
promot
patholog
remodel
zhu
et
al
summari
cardiac
autophagi
appear
function
predominantli
prosurviv
mechan
normal
mildli
stress
condit
excess
autophagi
present
howev
autophag
machineri
may
play
selfdestruct
role
lead
damag
myocardium
congest
heart
failur
role
autophagi
sever
neurodegen
diseas
includ
alzheim
diseas
ad
parkinson
diseas
pd
huntington
diseas
hd
rubinsztein
et
al
receiv
recent
attent
despit
appar
distinct
etiolog
neurodegen
disord
patholog
share
presenc
protein
inclus
aggreg
within
neuron
rubinsztein
thu
failur
protein
degrad
may
one
caus
neuron
cell
death
neurodegen
disord
despit
morpholog
evid
autophagi
activ
neuron
patient
ad
pd
hd
levin
yuan
mizushima
role
autophagi
neurodegen
disord
remain
unclear
circumst
describ
alway
easi
deciph
whether
presenc
autophagi
surviv
respons
form
program
cell
death
autophagi
seen
neuron
undergo
neurodegener
death
respons
fail
attempt
surviv
observ
suggest
role
autophagi
neurodegener
intervent
block
autophagi
increas
cell
death
would
suggest
surviv
role
wherea
decreas
cell
death
would
suggest
opposit
thu
experiment
clinic
studi
ascertain
autophagi
play
role
high
prioriti
contrast
studi
report
accumul
autophagosom
indic
activ
autophagi
act
protect
mechan
degrad
mutant
toxic
protein
experi
shown
reduc
autophag
activ
could
result
disturb
degrad
intracellular
protein
format
protein
aggreg
inclus
may
caus
cellular
toxic
disrupt
neural
function
hara
et
al
komatsu
et
al
induct
autophagi
enhanc
clearanc
cytoplasm
aggregatepron
protein
accumul
ubiquitin
aggreg
detect
central
nervou
system
mice
lack
accompani
neurodegener
abnorm
neurolog
sign
death
komatsu
et
al
similarli
mice
defici
develop
progress
deficit
motor
function
accompani
accumul
cytoplasm
inclus
bodi
neuron
hara
et
al
compon
iii
complex
posit
regul
autophagi
defici
mous
embryo
lead
sever
neural
tube
defect
associ
uncontrol
cell
prolifer
fimia
et
al
follow
morpholog
evid
autophagi
neurodegen
disord
like
ad
pd
hd
mizushima
studi
demonstr
role
autophagi
patholog
condit
pd
second
common
neurodegen
disord
agerel
diseas
character
rest
tremor
slow
movement
postur
instabl
muscl
rigid
janda
et
al
autophagi
found
play
import
role
intracellular
clearanc
asynuclein
asyn
major
compon
neuron
cytoplasm
inclus
lewi
bodi
character
pd
webb
et
al
overexpress
reduc
accumul
asyn
amelior
relat
neuron
patholog
featur
mous
model
spencer
et
al
recent
studi
link
mitophagi
defect
pd
associ
accumul
mitochondri
damag
exampl
parkin
critic
role
mitophag
remov
damag
mitochondria
mutat
gene
link
autosom
recess
pd
cesari
et
al
vivesbauza
et
al
ad
lead
caus
dementia
age
popul
close
link
shown
defect
autophagi
ad
observ
express
significantli
reduc
brain
patient
ad
defici
reduc
autophag
activ
neuron
also
acceler
bamyloid
accumul
promot
neurodegener
contrast
upregul
decreas
amyloid
deposit
thu
restor
autophagi
may
repres
effect
approach
treatment
ad
pickford
et
al
hd
neurodegen
genet
disord
caus
expans
polyglutamin
polyq
tract
huntingtin
htt
result
death
striatal
medium
spini
neuron
subsequ
disrupt
basal
ganglia
higher
function
eventu
lead
characterist
choreiform
movement
cognit
declin
psychiatr
problem
autophagi
implic
regul
turnov
htt
sarkar
et
al
main
compon
nuclear
cytosol
inclus
detect
hdaffect
neuron
knockdown
knockout
atg
gene
increas
format
aggreg
toxic
polyq
expans
protein
caenorhabd
elegan
autophagi
diseas
pharmacolog
taken
togeth
autophagi
play
protect
role
neurodegen
diseas
defect
autophagi
import
contributor
disord
thu
expect
modul
autophagi
activ
pharmacolog
approach
mean
might
emerg
novel
therapeut
strategi
neurodegen
diseas
process
age
close
associ
accumul
damag
protein
organel
particular
mitochondria
shown
c
elegan
rodent
decreas
gener
damag
protein
organel
associ
extens
life
span
levin
klionski
accumul
damag
protein
mitochondria
may
reflect
insuffici
protein
turnov
may
contribut
age
process
autophagi
particip
elimin
damag
protein
organel
reduc
reactiv
oxygen
speci
ro
product
promot
mitochondri
turnov
biogenesi
may
contribut
lifespan
extens
prevent
delay
develop
complic
associ
age
rubinsztein
et
al
normal
patholog
age
often
associ
reduc
autophag
degrad
may
result
accumul
protein
aggreg
damag
mitochondria
thu
contribut
agerel
cellular
dysfunct
cuervo
fact
role
autophagi
increas
life
span
studi
variou
model
system
yeast
matec
et
al
c
elegan
toth
et
al
fruit
fli
simonsen
et
al
activ
autophagi
potent
antiag
effect
inhibit
cellular
process
acceler
age
compromis
longevitypromot
effect
calor
restrict
cr
rubinsztein
et
al
cr
key
antiag
intervent
shown
contribut
extens
life
span
divers
eukaryot
organ
includ
yeast
fli
worm
rodent
mammal
colman
et
al
benefici
human
health
cr
potent
induc
autophagi
inhibit
autophagi
prevent
antiag
effect
cr
rubinsztein
et
al
suggest
effect
cr
longev
mediat
least
part
activ
autophagi
report
autophagi
gene
requir
longev
effect
dietari
restrict
c
elegan
provid
first
genet
evid
role
autophagi
extens
life
span
inhibit
mtor
also
extend
life
span
sever
model
organ
confer
protect
varieti
agerel
pathogenes
multipl
process
mrna
translat
autophagi
like
contribut
prolongev
effect
inhibit
johnson
et
al
evid
studi
yeast
invertebr
show
autophagi
requir
lifespan
extens
caus
dietari
restrict
rapamycin
administr
alver
et
al
bjedov
et
al
believ
exist
crosslink
molecular
mechan
regul
autophagi
age
cr
induc
autophagi
activ
andor
inhibit
mtor
signal
pathway
involv
stressresist
longev
also
involv
autophagi
regul
salminen
kaarniranta
induct
autophagi
may
also
benefici
treatment
infecti
diseas
cellular
process
defend
microorgan
via
select
degrad
pathogen
activ
innat
adapt
immun
levin
et
al
observ
autophag
activ
increas
host
infect
variou
bacteria
virus
rikihisa
munz
c
elegan
dictyostelium
discoideum
model
mutat
autophagi
gene
diminish
autophagi
render
host
suscept
infect
invas
bacteria
permit
intracellular
bacteri
replic
jia
et
al
overexpress
inhibit
replic
sindbi
viru
protect
cell
infect
suggest
autophagi
play
role
host
defens
viral
infect
liang
et
al
autophag
machineri
use
select
deliveri
microorgan
lysosom
process
call
xenophagi
cellular
process
degrad
variou
intracellular
invad
pathogen
bacteria
virus
kirkegaard
et
al
nakagawa
et
al
addit
degrad
infecti
agent
activ
autophagi
enhanc
antimicrobi
innat
adapt
immun
signal
deret
autophagi
may
function
innat
effector
mycobacteri
infect
receptordepend
orand
receptorindepend
patternrecognit
mechan
fabri
et
al
degrad
intracellular
pathogen
cytotox
microbi
virul
product
autophagi
may
support
cellular
surviv
pathogen
invas
howev
induct
autophagi
may
also
aid
bacteria
virus
invad
host
tissu
escap
host
defens
mechan
bacteria
porphyromona
gingivali
brucella
abortu
enter
cell
surviv
within
autophagosom
vacuol
infect
bacteria
intern
earli
endosomelik
vacuol
sequest
autophagosom
therebi
inhibit
fusion
autophagosom
lysosom
prevent
degrad
lysosom
hydrolas
dorn
et
al
marino
lopezotin
autophagi
may
also
provid
pathogen
nutrient
growth
substrat
metabol
pathway
addit
autophagi
use
certain
type
virus
replic
exampl
prentic
et
al
report
cellular
autophagi
requir
replic
corona
viru
mous
hepat
viru
mhv
therefor
autophagi
either
favor
unfavor
pathogen
infect
current
knowledg
role
autophagi
infect
suggest
depend
type
pathogen
autophag
machineri
either
use
virus
bacteria
infect
grow
within
host
cell
autophag
process
function
protect
mechan
infect
therefor
mani
circumst
autophagi
may
favor
unfavor
effect
exploit
autophagi
devis
new
strategi
treatment
infecti
diseas
appear
promis
also
challeng
larg
depend
complet
understand
role
autophagi
differ
type
stage
infect
addit
degrad
pathogen
previous
discuss
upregul
autophagi
may
facilit
optim
regul
innat
adapt
immun
signal
levin
deret
kuballa
et
al
autophagi
particip
traffick
event
deliv
microbi
nucleic
acid
antigen
endolysosom
compart
activ
innat
immun
schmid
munz
deliveri
viral
pathogen
tolllik
receptor
impair
secret
interferon
ifna
decreas
dendrit
cell
model
lee
et
al
effici
immun
respons
pathogen
involv
complex
intracellular
antigenprocess
event
found
autophagi
may
benefit
host
degrad
endogen
viral
protein
antigen
present
exampl
herp
simplex
viru
infect
autophagi
increas
present
endogen
viral
antigen
cell
major
histocompat
complex
mhc
class
molecul
english
et
al
autophagi
also
may
enhanc
present
major
histocompat
complex
class
ii
cell
import
mechan
control
homeostasi
cell
autophagi
appear
involv
develop
surviv
lymphocyt
exampl
lymphocyt
display
dramat
increas
cell
death
cell
fail
undergo
effici
prolifer
tcell
receptor
stimul
pua
et
al
autophag
machineri
function
innat
adapt
immun
sever
surfac
receptor
cytokin
involv
innat
adapt
immun
respons
also
stimul
autophagi
clearanc
intracellular
pathogen
instanc
tolllik
receptor
activ
autophagi
respons
pathogen
invas
delgado
et
al
cytokin
innat
adapt
immun
report
regul
autophagi
includ
ifng
tnfa
among
ifng
inbal
et
al
tnfa
djavaherimergni
et
al
stimul
autophagi
wherea
block
autophagi
harri
et
al
autophagi
also
link
immun
function
secret
proinflammatori
cytokin
autophagi
mitig
inflammatori
reaction
differ
mechan
rapid
remov
apoptot
corps
autophagi
amelior
tissu
inflamm
autophagydefici
embryo
demonstr
increas
inflamm
tissu
impair
clearanc
apoptot
cell
macrophag
overproduc
inflammatori
cytokin
treatment
lipopolysaccharid
suggest
autophagi
involv
control
endotoxininduc
inflammatori
immun
respons
saitoh
et
al
autophagi
also
inhibit
activ
inflammasom
secret
like
improv
qualiti
control
mitochondria
remov
ro
cytosol
mitochondri
dna
nakahira
et
al
consist
found
inhibit
mitophagi
lead
accumul
damag
rosgener
mitochondria
respons
activ
inflammasom
zhou
et
al
knowledg
role
autophagi
immun
strengthen
connect
found
crohn
diseas
autophagystimulatori
immunityrel
gtpase
irgm
two
gene
involv
autophagi
regul
massey
park
park
et
al
studi
suggest
potenti
role
deregul
autophagi
pathogenesi
crohn
diseas
genomewid
studi
link
sever
singlenucleotid
polymorph
gene
suscept
system
lupu
erythematosu
sle
suggest
involv
autophagi
autoimmun
diseas
levin
et
al
anoth
connect
autophagi
chronic
inflamm
found
cystic
fibrosi
lifethreaten
genet
disord
caus
mutat
gene
encod
cystic
fibrosi
transmembran
conduct
regul
cftr
luciani
et
al
defect
cystic
fibrosi
transmembran
conduct
regul
result
defici
autophagi
lung
epitheli
cell
restor
autophagi
overexpress
rescu
diseas
phenotyp
novel
therapeut
intervent
understand
role
autophagi
healthi
tissu
help
identifi
import
autophagi
diseas
develop
effect
autophagybas
autophagi
diseas
pharmacolog
therapi
essenti
identifi
key
target
autophagi
pathway
develop
new
therapeut
agent
discuss
earlier
autophagi
play
protect
destruct
role
diseas
state
thu
therapeut
purpos
would
valuabl
identifi
develop
pharmacolog
agent
induc
inhibit
cellular
process
varieti
potenti
druggabl
target
affect
autophagi
identifi
act
posit
regul
autophagi
variou
stress
report
laboratori
wu
et
al
cheng
et
al
cheng
et
al
autophagi
inhibitor
numer
studi
demonstr
autophagi
inhibit
pharmacolog
target
earli
late
stage
autophag
process
fig
tabl
list
compound
identifi
inhibitor
autophagi
like
drug
potenc
activ
select
safeti
well
pharmacolog
properti
pharmacokinet
absorpt
distribut
metabol
elimin
essenti
element
drug
ultim
clinic
util
inhibitor
target
earli
stage
autophagi
includ
wortmannin
hydrochlorid
inhibit
class
iii
disabl
format
autophagosom
inhibitor
act
late
stage
autophagi
includ
chloroquin
cq
bafilomycin
leupeptin
pepstatin
latter
compound
either
inhibit
fusion
autophagosom
lysosom
degrad
autolysosom
lysosomotrop
agent
cq
deriv
hcq
increas
lysosom
ph
prevent
digest
activ
hydrolas
lead
inhibit
fusion
autophagosom
lysosom
degrad
activ
autolysosom
amaravadi
et
al
bafilomycin
select
inhibitor
vacuolar
h
atpas
respons
acidifi
lysosom
digest
phase
autophagi
also
block
inhibitor
lysosom
proteolysi
leupeptin
pepstatin
autophagosom
lysosom
move
along
microtubul
fuse
microtubuledisrupt
agent
includ
nocodazol
colchicin
vinblastin
block
fusion
autophagosom
lysosom
yang
et
al
rubinsztein
et
al
pe
small
molecul
inhibitor
heat
shock
protein
impair
autophagi
activ
mtor
inhibit
induct
autophagi
thu
mtor
inhibitor
strong
induc
autophagi
activ
mtor
regul
class
pathway
inhibitor
stimul
autophagi
egfr
upstream
regul
class
pathway
inhibit
egfr
activ
autophagi
suppress
mtor
ampk
activ
autophagi
via
suppress
mtor
directli
stimul
activ
thu
activ
ampk
induc
autophagi
intracellular
level
neg
regul
autophagi
via
mtorindepend
mechan
inhibit
pathway
induc
autophagi
antiapoptot
protein
bclxl
interact
beclin
homolog
domain
therebi
inhibit
autophagi
thu
small
molecul
mimet
activ
autophagi
block
interact
class
iii
critic
autophagi
initi
inhibitor
suppress
autophagi
block
format
autophagosom
inhibitor
lysosom
enzym
lysosomotrop
agent
elev
lysosom
ph
inhibit
autophagi
block
fusion
autophagosom
lysosom
degrad
autolysosom
autophagi
diseas
pharmacolog
inhibitori
effect
lysosom
function
leu
et
al
monensin
inhibitor
protein
transport
inhibit
autophagi
prevent
fusion
autophagosom
lysosom
use
imagingbas
screen
liu
et
al
recent
identifi
highli
potent
small
molecul
inhibitor
autophagi
name
specif
potent
autophagi
inhibitor
promot
degrad
complex
via
inhibit
ubiquitinspecif
process
proteas
two
ubiquitinspecif
peptidas
target
deubiquitin
autophagi
activ
mtor
inositol
epiderm
growth
factor
receptor
egfr
bclxl
neg
regul
autophagi
thu
drug
target
protein
capac
induc
autophagi
fig
tabl
list
compound
identifi
activ
autophagi
inhibitor
rapamycin
analog
temsirolimu
everolimu
deforolimu
strong
induc
autophagi
rubinsztein
et
al
atpcompetit
inhibitor
mtor
trifluoromethyl
phenyl
h
thoreen
et
al
pyrido
methanol
chresta
et
al
inhibit
newli
develop
atpcompetit
inhibitor
mtor
n
benzamid
feldman
et
al
pyrazolo
phenyl
show
stronger
inhibitori
activ
compar
rapamycin
yu
et
al
autophagyinduc
efficaci
well
document
use
autom
cellbas
assay
balgi
et
al
found
rottlerin
potent
largeconduct
potassium
channel
open
inhibitor
protein
kinas
c
three
approv
drug
perhexilin
prophylact
antiangin
agent
niclosamid
teniacid
amiodaron
antiarrhythm
agent
activ
autophagi
inhibit
signal
activ
mtor
regul
class
pathway
neg
feedback
pathway
exist
oreilli
et
al
dual
inhibitor
signal
phenyl
propanenitril
furo
potent
induc
autophagi
suppress
autophagi
inhibit
lithium
phosphon
acid
xestospongin
b
chemic
antagonist
receptor
stimul
autophagi
criollo
et
al
egfr
upstream
regul
class
akt
pathway
known
suppress
autophagi
activ
mtor
therefor
induct
autophagi
might
contribut
effect
egfrtarget
therapi
inde
cetuximab
therapeut
antibodi
block
function
egfr
induc
autophagi
cancer
cell
li
fan
small
molecul
mimet
benzoyl
maiuri
et
al
ethoxycarbonyl
acid
ethyl
ester
kessel
reiner
inhibit
interact
increas
autophag
activ
fig
tabl
autophagi
also
pharmacolog
induc
via
activ
posit
regul
autophagi
metformin
wide
use
antidiabet
agent
activ
ampk
induc
autophagi
addit
mani
drug
activ
autophagi
divers
even
unknown
mechan
action
exampl
cytotox
agent
shown
induc
autophagi
cancer
cell
agent
includ
tnfrelat
apoptosisinduc
ligand
han
et
al
histon
deacetylas
inhibitor
vorinostat
saha
shao
et
al
ethyl
amino
methyl
phenyl
elli
et
al
panobinostat
elli
et
al
benzamid
tamoxifen
bursch
et
al
resveratrol
scarlatti
et
al
oridonin
cheng
et
al
b
temozolomid
cheng
et
al
arsen
trioxid
drug
tyrosin
kinas
inhibitor
imatinib
ertmer
et
al
dasatinib
milano
et
al
proteasom
inhibitor
bortezomib
hydroxi
methyl
zhu
et
al
antidepress
fluoxetin
maprotilin
cloonan
william
farnesyltransferas
inhibitor
manumycin
amino
amino
lonafarnib
pan
et
al
endoplasm
reticulum
stress
induc
thapsigargin
tunicamycin
angiogenesi
inhibitor
kringl
endostatin
ramakrishnan
et
al
also
induc
autophagi
despit
differ
mechan
action
tabl
recent
advanc
understand
role
function
autophagi
human
health
diseas
provid
excit
opportun
target
autophagi
treatment
human
ill
rubinsztein
et
al
follow
section
discuss
direct
may
particular
use
futur
investig
modul
autophagi
cancer
therapi
therapeut
target
autophagi
pathway
new
anticanc
strategi
extens
investig
depend
context
tumor
type
stage
autophagyenhanc
autophagyinhibit
agent
may
elicit
benefici
effect
treatment
cancer
use
autophagi
inhibitor
cancer
treatment
rational
inhibit
autophagi
cancer
treatment
gener
observ
increas
autophagi
often
observ
cancer
cell
appar
attempt
maintain
metabol
homeostasi
surviv
extern
stress
hypoxia
nutrient
depriv
chemotherapi
radiotherapi
rasmedi
transform
tumor
growth
appear
use
autophagi
evad
metabol
stress
cell
death
demonstr
inhibit
autophagi
pharmacolog
genet
mean
suppress
krasinduc
growth
human
breast
epitheli
cell
vitro
tumor
growth
anim
model
kim
et
al
inhibit
autophagi
use
cq
smallinterf
rna
sirna
inhibit
growth
tumorigen
pancreat
ductal
carcinoma
pdac
tumor
kra
mutat
cell
mous
xenograft
model
preclin
result
suggest
autophagi
might
exploit
new
therapeut
target
set
tumor
driven
oncogen
ra
may
lead
clinic
trial
use
autophagi
inhibitor
patient
rasdriven
tumor
abnorm
autophag
activ
also
observ
poorli
differenti
nonsmallcel
lung
cancer
associ
extens
intratumor
autophagi
diseas
pharmacolog
necrosi
consid
poor
prognost
factor
karpathi
et
al
autophagi
upregul
tumor
cell
subject
variou
stress
includ
chemotherapi
radiotherapi
block
autophagi
may
increas
effect
concomit
treatment
townsend
et
al
inhibit
autophagi
cqsensit
human
cancer
cell
subject
hypoxia
human
xenograft
subject
radiat
therapi
rouschop
et
al
shown
inhibit
autophagi
enhanc
efficaci
chemotherapi
target
therapi
cancer
increas
efficaci
associ
increas
tumor
cell
death
suppress
autophagi
via
knockdown
autophagi
gene
use
chemic
inhibitor
autophagi
cq
hcq
sensit
tumor
cell
effect
chemotherapeut
drug
rubinsztein
et
al
tamoxifen
amaravadi
et
al
tnfa
giampietri
et
al
proteasom
inhibitor
zhu
et
al
glycolyt
inhibitor
wu
et
al
choi
lee
tyrosin
kinas
inhibitor
gupta
et
al
histon
deacetylas
hdac
inhibitor
shao
et
al
carew
et
al
egfr
antibodi
inhibitor
li
fan
recent
report
blunt
autophagi
inhibit
significantli
increas
antitumor
effect
akt
inhibitor
phenyl
one
dihydrochlorid
cheng
et
al
b
also
found
combinatori
treatment
small
molecul
inhibitor
egfr
tyrosin
kinas
gefitinib
promot
switch
autophagi
apoptosi
enhanc
efficaci
gefitinib
human
glioma
cheng
et
al
dual
inhibitor
signal
activ
cytoprotect
autophagi
inhibitor
autophagi
cooper
dual
inhibitor
promot
tumor
cell
death
sensit
effect
inhibit
autophagi
antitumor
efficaci
chemotherapeut
agent
recapitul
preclin
model
mycinduc
lymphoma
amaravadi
et
al
colon
cancer
carew
et
al
prostat
cancer
glioma
basi
preclin
data
demonstr
target
autophag
surviv
reinforc
efficaci
anticanc
therapi
number
clinic
trial
launch
test
whether
inhibitor
autophagi
benefit
cancer
patient
tabl
known
autophagi
inhibitor
thu
far
cq
hcq
activ
evalu
clinic
trial
partli
pharmacolog
toxicolog
profil
two
drug
well
document
cq
origin
introduc
therapeut
agent
treat
malaria
still
use
effect
safe
antimalari
drug
furthermor
cq
use
treatment
rheumatoid
arthriti
system
lupu
erythematosu
amoeb
hepat
connect
tissu
disord
solomon
lee
retin
toxic
major
side
effect
cq
hcq
later
develop
modif
structur
cq
introduc
hydroxyl
group
end
side
chain
structur
modif
result
decreas
abil
cross
bloodretin
barrier
reduc
retin
toxic
townsend
et
al
favor
safeti
profil
make
hcq
prefer
cq
ruizirastorza
et
al
earli
result
cq
cancer
treatment
report
patient
glioblastoma
treat
surgeri
chemotherapi
radiotherapi
without
cq
sotelo
et
al
median
surviv
cq
arm
month
compar
month
control
sotelo
et
al
also
sever
ongo
phase
iii
trial
evalu
combin
hcq
cq
chemotherapeut
agent
patient
multipl
myeloma
brain
lung
breast
colorect
pancrea
kidney
prostat
cancer
tabl
result
inform
hold
potenti
increas
interest
field
b
use
autophagi
activ
cancer
treatment
discuss
earlier
evid
suggest
increas
autophagi
kill
cell
howev
weak
mani
studi
demonstr
autophagi
cytotox
treatment
prove
autophagi
contribut
cell
death
associ
equal
plausibl
increas
autophagi
set
fail
attempt
cell
surviv
definit
demonstr
cytotox
role
autophagi
inhibit
would
increas
surviv
fact
studi
demonstr
caus
role
autophagi
promot
cell
death
nonetheless
induct
autophag
cell
death
suggest
potenti
strategi
erad
tumor
cell
fact
sever
anticanc
drug
report
trigger
cell
death
autophagymedi
mechan
levi
thorburn
rapamycin
select
mtor
inhibitor
induc
autophagi
takeuchi
et
al
temsirolimu
anoth
inhibitor
mtor
whose
autophagyinduc
effect
attribut
antitumor
mechan
mantl
cell
lymphoma
yazbeck
et
al
likewis
inhibitori
effect
mtor
inhibitor
everolimu
lymphoblast
leukemia
associ
activ
autophagi
crazzolara
et
al
atpcompetit
inhibitor
yu
et
al
chresta
et
al
demonstr
anticanc
activ
sever
solid
tumor
vitro
vivo
current
phase
clinic
trial
tyrosin
kinas
inhibitor
dasatinib
report
enhanc
antiglioma
effect
temozolomid
trigger
autophag
cell
death
action
antagon
autophagi
inhibitor
milano
et
al
akt
inhibitor
induc
greater
autophag
respons
caus
cell
death
combin
radiotherapi
chemotherapi
fujiwara
et
al
use
alon
type
drug
possess
autophagyinduc
effect
also
found
potenti
applic
cancer
treatment
instanc
autophag
cell
death
may
contribut
anticanc
action
histon
deacetylas
hdac
inhibitor
vorinostat
saha
shao
et
al
liu
et
al
estrogen
receptor
antagonist
tamoxifen
bursch
et
al
antidepress
fluoxetin
maprotilin
cloonan
william
inhibit
autophagi
decreas
efficaci
agent
tumor
cell
cytotox
tumor
necrosi
factor
tnfa
fibrosarcoma
cell
also
associ
activ
autophagi
cheng
et
al
natur
product
arsen
trioxid
resveratrol
opipari
et
al
saponin
ellington
et
al
induc
autophag
cell
death
malign
glioma
ovarian
cancer
colon
cancer
respect
thu
conceiv
autophagyinduc
agent
may
also
use
cancer
therapi
abil
trigger
autophag
cell
death
attent
given
inhibitor
autophagi
given
autophagyinduc
autophagyenhanc
agent
therapeut
effect
autophagi
modul
cardiovascular
diseas
increas
evid
link
autophagi
normal
function
cardiomyocyt
pathogenesi
multipl
form
heart
diseas
suggest
compon
autophagi
diseas
pharmacolog
autophagi
pathway
may
includ
potenti
new
target
treat
cardiac
disord
autophagi
upregul
mani
cardiac
patholog
state
exert
protect
detriment
effect
contextdepend
mechan
pharmacolog
modul
autophagi
may
repres
new
therapeut
strategi
limit
myocardi
damag
cardiac
stress
tabl
far
nine
patent
disclos
use
autophagi
activ
inhibitor
treatment
cardiovascular
diseas
nemchenko
et
al
cardiac
autophagi
often
activ
respons
stress
enhanc
clearanc
misfold
harm
protein
rapamycin
potent
activ
autophagi
report
prevent
cardiac
hypertrophi
caus
thyroid
hormon
aortic
band
repress
exist
hypertrophi
result
pressur
overload
shioi
et
al
mcmullen
et
al
nishida
et
al
sulfaphenazol
sul
antimicrobi
agent
protect
heart
ir
injuri
reportedli
induc
autophagi
likewis
chloramphenicol
succin
shown
activ
autophagi
reduc
myocardi
damag
ir
salamercado
et
al
macrophag
degrad
extracellular
matrix
promot
death
smooth
muscl
cell
therebi
play
role
atherogenesi
clearanc
macrophag
atherosclerot
plaqu
autophagi
suggest
attract
therapeut
strategi
atherosclerosi
martinet
et
al
line
find
stentbas
deliveri
everolimu
shown
select
clear
macrophag
atherosclerot
plaqu
rabbit
activ
autophagi
without
alter
smooth
muscl
cell
verhey
et
al
situat
presenc
sever
pressur
overload
suppress
rather
activ
autophagi
might
benefici
instanc
trichostatin
inhibitor
histon
deacetylas
blunt
autophagi
inhibit
patholog
cardiac
remodel
sever
pressur
overload
cao
et
al
propofol
antioxid
agent
wide
use
anasthet
also
shown
inhibit
autophag
cell
death
limit
myocardi
damag
ir
injuri
rat
noh
et
al
granulocyt
coloni
stimul
tabl
preclin
studi
effect
autophagi
modul
variou
diseas
factor
gcsf
improv
surviv
cardiac
function
remodel
hamster
model
dilat
cardiomyopathi
benefici
effect
appear
associ
reduct
autophag
cell
death
also
reduct
autophagi
cardiac
myocyt
ir
associ
increas
cell
surviv
valentim
et
al
autophagi
play
protect
role
cardiomyocyt
expos
divers
form
patholog
insult
nutrient
depriv
effect
induc
autophagi
mammalian
cell
mizushima
intermitt
fast
protect
heart
ischem
injuri
attenu
cardiac
remodel
myocardi
infarct
like
induct
autophagi
howev
prolong
starvat
may
trigger
sever
cardiovascular
complic
cardiac
death
martinet
et
al
thu
select
activ
inhibitor
autophagi
prevent
treatment
cardiovascular
diseas
complic
date
clinic
data
report
efficaci
pharmacolog
modul
autophagi
cardiac
diseas
howev
like
drug
alreadi
clinic
use
may
stimulatori
inhibitori
effect
autophagi
tool
compound
may
elucid
path
forward
area
use
autophagi
modul
neurolog
disord
sever
neurodegen
diseas
character
accumul
intracellular
aggregatepron
protein
includ
polyqexpand
htt
hd
asyn
pd
amyloidb
ad
autophagi
play
critic
role
degrad
misfold
aggreg
protein
thu
activ
autophagi
facilit
degrad
toxic
protein
potenti
novel
approach
treatment
neurodegen
disord
tabl
experi
alreadi
shown
activ
autophagi
enhanc
clearanc
mutant
htt
protect
neurodegener
fli
model
hd
sarkar
et
al
autophagi
induc
rapamycin
report
promot
autophag
clearanc
reduc
toxic
variou
polyq
protein
includ
mutant
htt
ravikumar
et
al
berger
et
al
fli
mous
model
hd
rapamycin
induc
autophagi
protect
httinduc
neurodegener
ravikumar
et
al
rapamycin
analog
decreas
format
aggreg
lessen
symptom
hd
mous
model
diseas
ravikumar
et
al
rapamycin
also
increas
clearanc
asyn
cell
webb
et
al
lithium
sarkar
et
al
trehalos
sarkar
et
al
promot
clearanc
mutant
htt
asyn
via
autophag
degrad
mtorindepend
pathway
rapamycin
combin
lithium
show
greater
protect
neurodegener
hd
fli
model
compar
either
drug
alon
sarkar
et
al
inhibit
nitric
oxid
gener
n
g
nitrolarginin
methyl
ester
induc
autophagi
enhanc
degrad
mutant
htt
allevi
toxic
harm
protein
sever
model
hd
sarkar
et
al
combinatori
use
trehalos
rapamycin
show
addit
effect
clearanc
toxic
protein
increas
autophag
activ
sarkar
et
al
result
point
potenti
role
autophagi
activ
treatment
neurodegen
diseas
date
report
clinic
result
demonstr
modul
autophagi
inde
repres
effect
therapeut
intervent
devast
diseas
autophagi
modul
treatment
diseas
infecti
immun
diseas
describ
earlier
autophagi
implic
host
defens
infecti
agent
therefor
would
intrigu
determin
whether
target
autophagi
serv
effect
therapeut
strategi
infecti
diseas
sever
drug
protect
microbi
infect
also
induc
autophagi
tabl
phenanthrenyl
trifluoromethyl
phenyl
acetamid
novel
small
molecul
inhibitor
phosphoinositidedepend
induc
autophagi
clear
francisella
tularensi
human
leukem
cell
line
macrophag
chiu
et
al
salmonella
enterica
serovar
typhimurium
murin
macrophag
vitro
vivo
chiu
et
al
also
activ
form
vitamin
inhibit
replic
human
immunodefici
viru
hiv
human
macrophag
also
associ
enhanc
autophagi
campbel
spector
host
cell
infect
mycobacterium
tuberculosi
induct
autophagi
correl
activ
antimycobacteri
chemotherapi
kim
et
al
result
rais
possibl
drug
alreadi
clinic
use
treatment
infecti
diseas
exert
antiinfect
effect
least
partial
via
induc
autophagi
howev
data
result
vitro
anim
studi
unclear
whether
find
translat
clinic
treatment
certain
infect
recent
develop
autophagyinduc
peptid
shown
potenti
therapeut
efficaci
treatment
sever
infecti
diseas
shojikawata
et
al
peptid
deriv
region
bind
human
immunodefici
viru
interact
newli
identifi
neg
regul
autophagi
golgiassoci
plant
pathogenesisrel
protein
also
known
studi
demonstr
autophagyinduc
peptid
decreas
accumul
polyglutamin
expans
protein
aggreg
autophagi
diseas
pharmacolog
replic
sever
pathogen
well
reduc
mortal
mice
infect
chikungunya
west
nile
viru
shojikawata
et
al
would
intrigu
observ
effect
autophagyinduc
peptid
agent
clinic
trial
b
age
age
character
alter
dispos
damag
protein
organel
mitochondria
suggest
role
autophagi
process
donati
accordingli
shown
genet
disrupt
tor
extend
life
span
c
elegan
vellai
et
al
similar
observ
made
drosophila
kapahi
et
al
pharmacolog
inhibit
mtor
methionin
sulfoximin
rapamycin
increas
life
span
saccharomyc
cerevisia
power
et
al
resveratrol
polyphenol
compound
shown
promot
longev
sever
model
organ
autophagi
requir
lifespan
prolong
effect
agent
morselli
et
al
activ
autophagi
also
crucial
longevitypromot
effect
spermidin
cation
polyamin
trigger
autophagi
inhibit
histon
acetyltransferas
activ
variou
autophagyrel
transcript
eisenberg
et
al
thu
like
activ
autophagi
may
repres
new
strategi
intervent
age
modul
autophagi
could
among
class
futur
antiag
agent
goal
provid
perspect
autophagybas
pharmacotherapi
may
provid
new
arena
impact
human
diseas
relev
molecular
mechan
involv
autophagi
regul
impact
numer
patholog
condit
yield
startl
sometim
contradictori
new
insight
togeth
mani
basic
preclin
clinic
studi
suggest
us
role
modul
autophagi
treatment
human
ill
inde
target
autophagi
therapeut
strategi
variou
diseas
alreadi
begun
explor
shown
promis
particular
pharmacolog
approach
modul
autophagi
elicit
great
interest
ration
search
design
screen
test
inhibitor
activ
autophagi
becom
excit
activ
area
within
drug
discoveri
develop
expect
correct
autophagi
new
use
approach
treatment
ill
sever
drug
affect
autophagi
alreadi
test
anim
model
clinic
trial
diseas
cancer
cardiovascular
disord
earli
indic
promis
nevertheless
despit
promis
autophagi
modul
pharmacotherapeut
agent
number
problem
remain
need
resolv
clinic
modul
autophagi
variou
diseas
progress
problem
includ
follow
although
learn
great
deal
autophagi
molecular
biochem
cellular
level
precis
role
autophagi
individu
diseas
remain
incomplet
understood
mani
studi
limit
show
associ
presenc
autophagi
effect
drug
rather
implic
autophagi
directli
futur
studi
need
rigor
design
distinguish
precis
role
autophagi
diseas
state
respons
treatment
date
translat
preclin
observ
clinic
progress
rapidli
oncolog
major
opportun
progress
exist
sever
therapeut
area
includ
cardiolog
neurosci
infecti
diseas
autoimmun
like
diseas
area
segment
popul
like
respond
other
therebi
requir
identif
predict
pharmacodynam
surrog
endpoint
biomark
current
drug
describ
modul
autophagi
directli
specif
regul
autophagi
process
rather
act
pathway
involv
activ
inhibit
cellular
process
rais
question
specif
develop
select
inhibitor
activ
act
directli
regulatori
target
reli
larg
identif
understand
key
target
control
autophagi
elucid
molecular
structur
target
addit
sophist
discoveri
autophagyspecif
ligand
increas
may
possibl
use
concept
extant
area
pharmacolog
discov
function
select
autophagi
modul
appropri
signal
bia
maxim
therapeut
effect
minim
side
effect
facilit
discoveri
develop
autophagytarget
drug
sensit
effect
reliabl
accur
highthroughput
screen
ht
assay
would
need
establish
chemic
librari
enrich
new
scaffold
modul
autophagi
either
inhibitor
activ
expect
administ
combin
therapeut
agent
possibl
drugdrug
interact
pharmacokinet
pharmacodynam
might
present
potenti
problem
consid
design
develop
autophagytarget
drug
therapeut
regimen
conclus
grow
interest
cellular
autophagi
among
biomed
commun
hope
provid
uniqu
pharmacolog
point
view
opportun
potenti
applic
autophagytarget
pharmacolog
agent
therapeut
intervent
variou
human
diseas
varieti
human
disord
found
associ
chang
activ
autophagi
import
cellular
process
consid
viabl
target
drug
discoveri
pharmacolog
modul
autophagi
remedi
provid
unusu
opportun
explor
base
discuss
reason
believ
like
apoptosistarget
drug
alreadi
shown
degre
success
clinic
set
new
therapeut
agent
modul
autophagi
soon
emerg
come
clinic
applic
benefit
human
health
autophagybas
pharmacotherapi
becom
new
subject
pharmacolog
